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Abstract
The patient’s experience of their own healthcare is an important aspect of care quality that has been shown to 
improve clinical and other outcomes. Very little is currently known about patient experience in the management 
of multimorbidity, although preliminary evidence suggests that it may be poor. Individuals with multimorbid-
ity report better experiences of care when they are knowledgeable and involved in the decision-making, when 
their care is well coordinated, and communication is good. A greater focus on disease prevention, stronger col-
laboration between health and social care services, and the provision of more integrated care for people with 
mental and physical health problems would also help to improve the patient experience. Advocacy groups can 
amplify the patient voice and improve access to care, as well as provide information and support to patients and 
their families. Patients have an important role in preventing multimorbidity and improving its management, and 
should be involved in the development of health policies and the delivery of healthcare services. Inequalities in 
access to quality healthcare must also be addressed.
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emotional support, physical comfort, communication 
and education, continuity and transition, access to care, 
and coordination of care [1]. Patients place a high priority 
on patient-centred care, and a good patient experience 
has been shown to improve clinical and other outcomes 
[2–7]. 
Very little is known about patient experience in the 
management of multimorbidity. Studies conducted to 
date in patients with long-term conditions have tended 
to focus on single conditions; although one American 
study found lower ratings of doctor–patient communica-
tion amongst people with multiple long-term conditions 
[8], and a recent British primary care study reported 
worse experiences in patients with multimorbidity [9]. 
To explore this issue more fully, this article presents 
the experiences of care reported by three individuals 
Introduction
There is growing interest amongst researchers, health-
care providers, and policymakers in evaluating the 
“patient experience” when assessing and attempting 
to improve the quality of care. Patient experience is a 
measure of “patient-centredness”, which includes con-
cepts such as respect for patient preferences and values, 
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with various multimorbidities, focusing on what went 
well for them and what could be improved. For these 
individuals, their own experiences of care have led them 
towards roles of advocacy – working with patient organ-
izations to represent the views of people with similar 
conditions, campaigning for change where change is 
needed, and providing support to other people on simi-
lar journeys. This article also describes the role of the 
European Commission as a patient advocate and presents 
the first results from a pan-European study evaluating 
perceptions of access to healthcare by patients and care 
providers.
Amplifying the patient voice within Europe
Karin Kadenbach
As politicians, it is our responsibility to provide as 
many solutions for as many different groups of people as 
possible, and when we look at the delivery of health ser-
vices, we must listen and learn from everyone, including 
patients themselves. We have all been patients at some 
point in our lives and have benefitted from the knowl-
edge and skills provided by the healthcare professionals 
we have encountered. And knowledge is the key. One of 
the biggest issues we are facing in the European Union 
(EU) at the moment is how we gather and share the 
information and knowledge we have built within our 
member states. Every country in the EU collects out-
comes data, but the use of different methodologies and 
systems precludes us from sharing this information read-
ily and comparing outcomes between countries. One of 
our most urgent tasks at the European level is to deliver 
reliable outcomes data (in line with data-protection 
measures, which include information on the patient 
experience) to policy- and decision-makers. We need to 
learn from the best and ensure that this experience and 
knowledge are shared.
The European Semester, which is the EU’s annual 
cycle of economic policy guidance and surveillance, has 
increasingly been focusing on the sustainability of health 
systems [10]. The centrepiece of the European Semester 
framework is the publication of its country-specific rec-
ommendations (CSR), which set out recommendations 
for national governments on how to reach the goals of 
the Europe 2020 Strategy to maintain economic stabil-
ity and growth [11]. In 2015, 11 countries received a 
recommendation relating to health, although, perhaps 
disappointingly, only two related to long-term care or 
ageing, and none related to the patient experience of 
care [11]. The European Semester process is a relatively 
new process that is gradually influencing health systems 
in the EU and has the potential to enhance the role of 
patients in helping to shape health policies across the 
region. To do so, we must ensure that the patient voice 
is amplified, the patient experience is monitored, and 
patients are empowered to influence change. 
How patient power can change clinical practice
Luís Mendão
Living with multimorbidities resulting from largely pre-
ventable conditions (e.g. human immunodeficiency virus 
[HIV] and hepatitis C virus infections) brings into sharp 
focus the need to invest in more powerful evidence and 
rights-based prevention strategies. People with HIV and 
acquired immune deficiency syndrome (AIDS) played 
a crucial part in the research advocacy for innovations 
that have enabled their survival and have increased the 
safety and tolerability of their treatments. However, they 
are now living with the long-term consequences of anti-
retroviral and other therapies, which are associated with 
the development of metabolic complications and cardio-
vascular disease. The risk of transmissible diseases, such 
as hepatitis and HIV, and their long-term health conse-
quences are greatest amongst those with mental health 
issues and problems with addiction, and typically affect 
people between the ages of 25 and 45 years. Primary 
prevention strategies targeted at high-risk groups, such 
as these, are urgently required and are likely to be cost-
effective in the long term. In Portugal, as in many other 
countries, we see a major imbalance between the invest-
ment made in HIV/AIDs prevention and the investment 
made in treating it, with 85% of the healthcare budget 
spent on pharmaceuticals, approximately 10–15% on 
medical care, and only 2% on primary prevention. 
To ease the burden of multimorbidity on the individual 
and to improve the patient experience, greater collabo-
ration between health and social care providers, with all 
services offered under one roof, would lessen the treatment 
burden and help to tackle social exclusion, discrimination, 
and stigma. More sustainable, regulated, and transparent 
business models should be developed to address the high 
cost of pharmaceutical medications and shift the focus from 
one of “cost” to one of “investment for return”. Incen-
tives should be available to reward good practice and the 
attainment of good clinical outcomes – penalties should be 
applied if these outcomes are not achieved.
The European AIDS Treatment Group (EATG) [12], 
which is close to my heart, stands as an exemplar of how 
patients can help change clinical practice by participating 
in clinical research. Working alongside the pharmaceu-
tical industry, and after lobbying hard, the EATG helped 
to persuade the industry to start including patients with 
specific comorbidities and multimorbidities in later-stage 
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clinical trials. As a result, many of the new hepatitis C 
medicines entered the market with sufficient data and 
indications to be used by patients with multimorbidi-
ties, such as those co-infected with HIV and those with 
blood disorders. Patient power also changed the way that 
hepatitis C was diagnosed and treated in Portugal, with 
half of all patients with a diagnosis of hepatitis C now 
on direct antiviral treatment. Patient organizations, such 
as the EATG, can help break down the barriers to inte-
grated care for people with multimorbidity by working 
together across disease boundaries – something that is 
now being achieved for people with HIV/AIDs and 
associated conditions.
Good business models are those that are affordable, 
sustainable, and meet the needs of patients. Patients can, 
and should, be involved in their own development.
Involve and empower: tackling multimorbidity 
for people with mental health problems
Bert Aben
Bipolar disorder is a severe psychiatric condition that 
frequently co-exists with long-term physical health prob-
lems, such as thyroid disorders, kidney disease, chronic 
pain, chronic obstructive airways disease, and diabetes 
[13]. Multimorbidity is common. People with bipolar 
disorder often live unhealthy lifestyles, which, along with 
the adverse effects of antipsychotic medications, contrib-
ute to high rates of cardiovascular disease and premature 
death [13]. I have bipolar disorder that I have learnt to live 
with; however, in the year 2000, I was diagnosed with 
diabetes and subsequently suffered a heart attack. Fortu-
nately, I live close to a hospital, and survived to tell my 
story. Fortunately, too, I live in the Netherlands, which, 
overall, provides good quality care for people with men-
tal health problems, with specialist clinicians – internists 
– managing both the physical and psychological aspects 
of the condition. In my experience, problems can arise 
when different specialists are involved in managing mul-
tiple conditions, especially when it comes to medication 
management and the potential for drug interactions. 
The collective voice of people with mental health 
problems is relatively quiet, and we often rely on advo-
cates to speak on our behalf. Organizations such as the 
Global Alliance of Mental Illness Advocacy Networks-
Europe (GAMIAN-Europe) [14] offer us a much-needed 
voice, helping to put patients at the heart of the Euro-
pean healthcare debate. GAMIAN-Europe, which 
represents approximately 50 European patient organiza-
tions, believes that patients can, and should, play a key 
role in developing positive and proactive policies on 
mental health issues, and works to provide information 
and support, facilitate open and inclusive dialogue, and 
share examples of good practice across the EU. It is my 
belief that only by involving patients and empowering 
them to get healthy and to stay healthy will any real 
progress be made on the issue of multimorbidity. There 
is much more work still to be done to achieve this goal.
Improving the patient experience through good 
care coordination and knowledge
Wolfram Nolte
A diagnosis of metastatic colon cancer in 2004 changed 
my life completely. It forced me to face my own mor-
tality, to learn to live without my colon, and to endure 
punishing rounds of chemotherapy and its long-term 
side effects. It also forced me to actively engage with 
patient support groups, to become an expert in my con-
dition, and to recognize the value of patient advocacy 
during difficult periods of life. Today, I spend much of 
my time working with advocacy groups associated with 
my type of cancer in the hope that I can help support 
other people facing similar issues.
I have been fortunate to have received treatment for 
my cancer and other comorbidities from medical teams 
that are well coordinated, discuss and prioritize my 
healthcare needs, keep me fully informed, and involve 
me in the decision-making. When my latest round of 
chemotherapy needed to be paused to allow me to have 
a much-needed hip replacement, my oncologist and 
orthopaedic surgeon worked closely together to ensure 
my risk was minimized and that my chemotherapy could 
recommence as soon as it was safe to do so. 
My experience as a patient advocate has taught me 
how to communicate more effectively with healthcare 
professionals and how to play an active part in my own 
medical care. Unfortunately, many other patients I have 
encountered in my work as a patient advocate are less 
well equipped to navigate their way around complex 
healthcare systems and many do not receive patient-cen-
tred or coordinated care. Health systems are currently 
not designed to enable patients to contribute to their 
own healthcare and patient input is rarely sought when 
health policies are being discussed. 
Patients can play an important role in managing 
their own multimorbidities, but health systems must be 
designed to encourage patient advocacy, and patients 
must be knowledgeable and able to communicate 
effectively with their healthcare teams. Good care coor-
dination and equipping patients with the knowledge and 
skills needed to navigate the healthcare system would go 
a long way towards improving the patient experience 
when multimorbidity strikes.
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Improving access to quality healthcare in 
Europe: the Patient Access Partnership
Stanimir Hasardzhiev
Patients living with multimorbidity need coordinated 
care that is patient-centred and built around shared deci-
sion-making if their needs are to be truly met and their 
experiences of care improved. Unfortunately, although 
there is a growing commitment to these principles, the 
reality for most patients in the EU is that care is frag-
mented and poorly coordinated. There are also growing 
inequalities in terms of access to quality healthcare for 
patients, especially in lower-income countries and those 
struggling with large budget deficits. 
The Patient Access Partnership (PACT) [15] is a joint 
initiative led by the Bulgarian National Patients’ Organi-
zation [16] and the European European Patients’ Forum 
Forum [17], and involves multiple stakeholders, including 
patients, European policymakers, healthcare profession-
als, academia, and the pharmaceutical industry. The 
overall vision of PACT is to enable different stakeholders 
to join forces to develop sustainable solutions to improve 
access to quality healthcare across Europe. “Access” has 
been defined by the group as encompassing the five As 
(5As): availability, adequacy, accessibility, affordability, 
and appropriateness. 
To try to measure “access” and understand how vari-
ous stakeholders in Europe perceive access, the PACT 
has developed a short questionnaire to evaluate different 
elements of the healthcare system and to identify whether 
the 5A principles analyse access sufficiently. The ques-
tionnaire has been validated in five pilot countries and is 
being rolled out to all 28 EU countries. The first results 
available from Belgium, Bulgaria, Cyprus, Estonia, 
France, and Spain have identified significant differences 
between the countries in terms of all five aspects of access 
to healthcare services and between different stakehold-
ers within each country. For example, the availability of 
primary healthcare services was generally considered to 
be good by all stakeholders in Belgium, but considered 
poor by stakeholders in Estonia. In Cyprus, access to 
long-term care was considered to be adequate by health-
care providers, but inadequate by patient organizations 
and the pharmaceutical industry. Access to specialist 
physicians differed markedly between Bulgaria and 
Belgium, and access to medical devices appeared to be 
better in France than in Estonia. The affordability of 
patented medication was considered to be good by most 
stakeholders in Spain, but poor by the pharmaceutical 
industry in Belgium. 
Overall, the study has so far confirmed that all five 
aspects of “access” are relevant and should be evaluated, 
and that all stakeholders should be examined to gain the 
fullest picture and to identify all perspectives. The results 
from all remaining EU countries are currently being 
evaluated and will be shared soon. However, the pre-
liminary analysis demonstrates that similar conclusions 
will be drawn from the second wave of answers received.
Summary and conclusions
Living with multimorbidity poses numerous challenges to 
the individual, and healthcare systems can help to alleviate 
or intensify that burden. The patient’s experience of care is 
an important aspect of care quality and, if the management 
of multimorbidity is to improve, a better understanding of 
this concept is required. Patients living with multimorbid-
ity appear to have a better experience of care and better 
outcomes when their care is well coordinated, they are 
involved in the decision-making, and communication 
between all parties is good. Greater investments should 
be made in preventing multimorbidity and on simplifying 
care pathways. Patients have an important role in improv-
ing the management of multimorbidity, and patients 
should be involved in the future development of health 
policies and healthcare services. To make the healthcare 
systems more accessible, effective, and tailored to the needs 
of patients with multimorbidity, a multiple stakeholder 
approach is needed, involving policymakers, healthcare 
professionals, industry, and the patients themselves.
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